HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Estee Lauder

This article was originally published in The Rose Sheet

Executive Summary

Expanding Creme de la Mer prestige skin care line with two cleansers and two tonics. Manufactured using the company's "deconstructed waters" process, which "virtually splits water molecules," the new products contain "charged water [that] acts as a generator to enhance the energy and performance of other ingredients" in the formulas, promotions for the new products claim. The cleansers, available as a lotion or gel, "clean and purify the skin without disrupting even the most sensitive complexion," while the tonics "revitalize and enliven" skin. The tonics are priced at $60 for 6.7 oz. and the cleansers cost $65 for 6.7 oz. Recommended to prepare skin before use of La Mer moisturizing cream, the original product in the line, the new formulas are available in limited prestige doors including Neiman Marcus...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005456

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel